inDemic is an expert-driven non-profit that provides knowledge management and science-driven information and opinion on a wide range of pandemic solutions that helps medical researchers, policymakers, and the public make informed decisions.
In this video interview, we discuss the strengths and limitations of COVID-19 vaccine candidates with Dr. Deborah Fuller, Professor of Microbiology at University of Washington. Her lab, which studies influenza, HIV, and Zika virus, is currently focused on immunity against COVID-19 and the development of novel vaccination strategies against SARS-CoV-2. Her lab’s work has resulted in over a dozen patents and two startup biotech companies.
In this video interview, we discuss vaccine hesitancy, first in measles as a historical backdrop, then for a potential or soon-to-be FDA authorized COVID-19 vaccine. Dr. Abram Wagner, research assistant professor of epidemiology at the University of Michigan, joins us to discuss recent research on vaccine hesitancy. His research looks at evidence-based programs and policies to control vaccine-preventable diseases. He currently holds a grant from the National Science Foundation that looks at behaviors and acceptance of a COVID-19 vaccine over time and across several regions, including the United States, India, and Taiwan.
